SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053320
Filing Date
2020-11-12
Accepted
2020-11-12 08:15:57
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-10q_20200930.htm 10-Q 2579919
2 EX-10.9 hrmy-ex109_551.htm EX-10.9 21892
3 EX-31.1 hrmy-ex311_173.htm EX-31.1 17872
4 EX-31.2 hrmy-ex312_172.htm EX-31.2 19588
5 EX-32.1 hrmy-ex321_170.htm EX-32.1 8067
6 EX-32.2 hrmy-ex322_171.htm EX-32.2 8120
  Complete submission text file 0001564590-20-053320.txt   7717362

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hrmy-20200930.xml EX-101.INS 1269977
8 XBRL TAXONOMY EXTENSION SCHEMA hrmy-20200930.xsd EX-101.SCH 59743
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrmy-20200930_cal.xml EX-101.CAL 58416
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrmy-20200930_def.xml EX-101.DEF 231913
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrmy-20200930_lab.xml EX-101.LAB 445202
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrmy-20200930_pre.xml EX-101.PRE 372349
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 201303529
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences